Primary Site >> Liver Cancer
Gene >> CD274
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Investigation on the effects of soluble programmed death-1 (sPD-1) enhancing anti-tumor immune response. PMID: 15791831 |
Ref: Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. PMID: 21213212 |
Ref: Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. PMID: 22396772 |
Ref: PD-L1 and Survival in Solid Tumors: A Meta-Analysis. PMID: 26114883 |
Ref: Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options. PMID: 26661118 Ref: CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation. PMID: 27245433 Ref: PD-L1 expression in human cancers and its association with clinical outcomes. PMID: 27574444 Ref: Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma. PMID: 27999748 |
Ref: Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma. PMID: 28363643 Ref: Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis. PMID: 28471952 Ref: Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. PMID: 28624577 Ref: Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma. PMID: 28627705 Ref: Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. PMID: 28648905 |
Ref: Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. PMID: 29556041 Ref: Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. PMID: 29593314 Ref: Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation. PMID: 29642405 Ref: Association Between Expression Level of PD1 by Tumor-Infiltrating CD8(+) T Cells and Features of Hepatocellular Carcinoma. PMID: 30145359 Ref: The roles of PD-1/PD-L1 and its signalling pathway in gastrointestinal tract cancers. PMID: 30161295 Ref: Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists. PMID: 30196908 Ref: Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives. PMID: 30387047 |